Update Reimbursement Scheme Metoject®

From January 1, 2025 the use of Metoject Pen® 7.5mg will be fully reimbursed by the Health Insurer. For this reason the Reimbursement Scheme of Metoject Pen® 7.5mg will be terminated as of January 1^st.

Conditions

Now the Reimbursement Scheme of Metoject® 7,5mg will be terminated, issues of before the 1^st January 2025 can be submitted till April 1^st, 2025 the latest.  After that period no more claims can be submitted.

Who can submit a claim

Only patients or their carer can claim the Personal Contribution for Metoject® 7,5mg  online or by post. Online will be the fastest option. Pharmacists cannot claim this medicine on behalf of the patient.

For more information check out the Metoject Pen® 7,5mg  medicine page